课题基金 / 基金详情

Virus-Host Interactions that Lead to Epilepsy

Virus-Host Interactions that Lead to Epilepsy
导致癫痫的病毒-宿主相互作用
批准号:
8387015
负责人:
Robert S Fujinami
金额:
$30.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-15 至 2014-06-30

项目摘要

项目成果

Robert S Fujinami的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):中枢神经系统(CNS)的病毒感染可导致脑炎。病毒性脑炎是癫痫的危险因素。癫痫的发病率约为1%至3%,影响着大约250万美国人和全球5000多万人。癫痫发作是由于大脑内兴奋性和抑制性输入之间的不平衡造成的。脑炎和由此对中枢神经系统造成的损害可以改变这些输入。感染引发的癫痫通常对许多已有的抗癫痫药物无效。大约30%的癫痫患者对现有的抗癫痫药物无效。因此,寻找新的癫痫生物学模型和潜在的新的治疗方法对公众健康具有重要意义。不同的病毒感染可以引起脑炎,从而导致癫痫发作。这些病毒包括疱疹病毒,如人类疱疹病毒6型、流感病毒、轮状病毒、腺病毒、呼吸道合胞病毒和小核糖核酸病毒。例如,人类微小核糖核酸病毒,肠道病毒71型,会导致脑炎,患者经常出现癫痫发作。困扰这一领域的一个问题是,目前还没有好的实验动物模型来研究病毒性脑炎如何导致癫痫。以前的动物模型曾用不同的病毒感染过兔子、大鼠和小鼠。这些动物会患上急性脑炎和癫痫,但会死于感染。泰勒氏小鼠脑脊髓炎病毒(TMEV)是一种嗜神经的小核糖核酸病毒。我们开发了一种新的模型,在该模型中,C57BL/6小鼠感染TMEV的Daniels病毒(DAV)株会在感染后3-10天内导致急性癫痫发作。小鼠会恢复,但在一段可变的潜伏期后,小鼠开始自发癫痫发作。这是第一个感染驱动的颞叶癫痫模型。我们建议在特定的目标1中测试假设,即直接病毒感染海马体锥体细胞导致癫痫的发展。在特定的目标2中,我们假设DAV感染针对中枢神经系统内的区域产生细胞因子风暴,从而导致神经元功能障碍和死亡。相关性:高达20%的病毒性脑炎幸存者会患上癫痫。该模型是首个感染驱动的癫痫模型。其他动物模型使用电刺激或神经毒性物质,杀死和/或改变大脑不同部分的神经元,导致自发癫痫发作。我们的病毒模型可能更相关,特别是对于使用抗炎方法测试新的治疗策略。如上所述,约30%的癫痫患者对现有的抗癫痫药物无效,最近FDA建议对11种披露自杀风险的癫痫药物附加警告。因此,有必要采取新的方法。
英文摘要
DESCRIPTION (provided by applicant): Viral infections of the central nervous system (CNS) can result in encephalitis. Viral encephalitis is a risk factor for epilepsy. Epilepsy has an incidence of about 1 to 3% and affects about 2.5 million Americans and more than 50 million individuals worldwide. Seizures result from imbalances between excitatory and inhibitory inputs within the brain. Encephalitis and resulting damage to the CNS can alter these inputs. Infection- initiated seizure disorders are often refractory to many established anti-epileptic drugs. Approximately 30% of individuals with epilepsy are refractory to currently existing anti-seizure medications. Therefore, finding new biological models for epilepsy and potentially new therapeutics are important for the public health. Different virus infections can cause encephalitis that result in seizures. These viruses include herpes viruses such as human herpes virus type-6, influenza viruses, rotaviruses, adenovirus, respiratory syncytial virus and picornaviruses. For example, the human picornavirus, Enterovirus 71, causes encephalitis where patients often present with seizures. A problem that has plagued this field is that a good experimental animal model is not available to investigate how virus encephalitis can lead to epilepsy. Previous animal models have infected rabbits, rats and mice with different viruses. These animals develop acute encephalitis and develop seizures but succumb to the infection. Theiler's murine encephalomyelitis virus (TMEV) is a neurotropic picornavirus. We have developed a new and novel model where infection of C57BL/6 mice with the Daniels virus (DAV) strain of TMEV leads to acute seizures between days 3 and 10 post infection. Mice recover but after a variable latent period mice start to have spontaneous seizures. This is the first infection driven model of temporal lobe epilepsy. We propose to test in Specific Aim 1 the hypothesis that direct virus infection of pyramidal cells of the hippocampus leads to the development of seizures. In Specific Aim 2 we hypothesize that DAV infection targets a cytokine storm to regions within the CNS that leads to neuronal dysfunction and death. Relevance: Up to 20% of individuals who survive viral encephalitis develop epilepsy. This model is the first infection driven model for epilepsy. Other animal models use electrical stimulation or neurotoxic substances that kill and/or alter neurons in different parts of the brain leading to spontaneous seizures. Our viral model is potentially more relevant particularly for the testing of new therapeutic strategies using an anti- inflammatory approach. As mentioned above about 30% of individuals with epilepsy are refractory to existing anti-seizure medications, and recently the FDA is recommending that warnings be attached to eleven epilepsy drugs disclosing the risk of suicide. Therefore, new approaches are warranted.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Viral-induced axonopathy: mechanisms of damage and repair
  • 批准号:
    10077064
  • 项目类别:
  • 资助金额:
    $16.17万
  • 财政年份:
    2020
  • 负责人:
    Robert S Fujinami
  • 依托单位:
Viral-induced axonopathy: mechanisms of damage and repair
  • 批准号:
    9014906
  • 项目类别:
  • 资助金额:
    $36.88万
  • 财政年份:
    2016
  • 负责人:
    Robert S Fujinami
  • 依托单位:
Viral-induced axonopathy: mechanisms of damage and repair
  • 批准号:
    9243327
  • 项目类别:
  • 资助金额:
    $36.88万
  • 财政年份:
    2016
  • 负责人:
    Robert S Fujinami
  • 依托单位:
Mouse Pneumotropic Virus Infection: A Model for JC Virus Latency and Reactivation
  • 批准号:
    8874456
  • 项目类别:
  • 资助金额:
    $7.45万
  • 财政年份:
    2015
  • 负责人:
    Robert S Fujinami
  • 依托单位:
海外基金